1. Home
  2. GBIO vs EDRY Comparison

GBIO vs EDRY Comparison

Compare GBIO & EDRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GBIO
  • EDRY
  • Stock Information
  • Founded
  • GBIO 2016
  • EDRY 2018
  • Country
  • GBIO United States
  • EDRY Greece
  • Employees
  • GBIO N/A
  • EDRY N/A
  • Industry
  • GBIO Biotechnology: Pharmaceutical Preparations
  • EDRY Marine Transportation
  • Sector
  • GBIO Health Care
  • EDRY Consumer Discretionary
  • Exchange
  • GBIO Nasdaq
  • EDRY Nasdaq
  • Market Cap
  • GBIO 29.5M
  • EDRY 27.3M
  • IPO Year
  • GBIO 2020
  • EDRY N/A
  • Fundamental
  • Price
  • GBIO $6.00
  • EDRY $10.90
  • Analyst Decision
  • GBIO Buy
  • EDRY
  • Analyst Count
  • GBIO 4
  • EDRY 0
  • Target Price
  • GBIO $10.67
  • EDRY N/A
  • AVG Volume (30 Days)
  • GBIO 792.1K
  • EDRY 1.0K
  • Earning Date
  • GBIO 08-12-2025
  • EDRY 08-11-2025
  • Dividend Yield
  • GBIO N/A
  • EDRY N/A
  • EPS Growth
  • GBIO N/A
  • EDRY N/A
  • EPS
  • GBIO N/A
  • EDRY N/A
  • Revenue
  • GBIO $21,230,000.00
  • EDRY $49,707,775.00
  • Revenue This Year
  • GBIO N/A
  • EDRY N/A
  • Revenue Next Year
  • GBIO N/A
  • EDRY $28.45
  • P/E Ratio
  • GBIO N/A
  • EDRY N/A
  • Revenue Growth
  • GBIO 61.15
  • EDRY N/A
  • 52 Week Low
  • GBIO $3.00
  • EDRY $7.60
  • 52 Week High
  • GBIO $29.40
  • EDRY $20.90
  • Technical
  • Relative Strength Index (RSI)
  • GBIO 57.46
  • EDRY 55.56
  • Support Level
  • GBIO $5.91
  • EDRY $10.62
  • Resistance Level
  • GBIO $6.48
  • EDRY $11.15
  • Average True Range (ATR)
  • GBIO 0.50
  • EDRY 0.18
  • MACD
  • GBIO -0.03
  • EDRY 0.03
  • Stochastic Oscillator
  • GBIO 68.12
  • EDRY 74.25

About GBIO Generation Bio Co.

Generation Bio Co is a genetics medicine company focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable differentiated therapeutic applications. Its first platform is a potent, selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.

About EDRY EuroDry Ltd.

EuroDry Ltd is a holding company. It is a provider of ocean-going transportation. The company owns and operates dry bulk carriers that transport bulk such as iron ore, coal, and grains, and minor bulks such as bauxite, phosphate, and fertilizers. It operates under one operating and one reportable segment, that of operating dry bulk vessels.

Share on Social Networks: